Capital Construction Mid-Year Snapshot: Pharma-Bio Industry to Invest More Than $16 Billion in 2013 Project Starts, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 06/20/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2013 almost halfway complete, the North American Pharmaceutical-Biotech Industry is more than holding its own. In January 2013, the industry as a whole had more than $17 billion in reported capital and maintenance projects scheduled to kick off throughout the year. Six months later, that total has dropped to $16.3 billion.
Other companies featured: Baxter International Corporation (NYSE:BAX), Perrigo (NYSE:PRGO), Bristol-Myers Squibb (NYSE:BMY)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=236065&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Add to Digg Bookmark with del.icio.us Add to Newsvine